Similar articles for PMID: 31898484

Year	Number of Results
2002	2
2004	1
2007	1
2009	1
2010	1
2011	1
2012	2
2013	4
2014	4
2015	4
2016	4
2017	13
2018	7
2019	21
2020	17
2021	21
2022	6
2023	5
2024	1

1

Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors.

Zhong W, Myers JS, Wang F, Wang K, Lucas J, Rosfjord E, Lucas J, Hooper AT, Yang S, Lemon LA, Guffroy M, May C, Bienkowska JR, Rejto PA. Zhong W, et al. BMC Genomics. 2020 Jan 2;21(1):2. doi: 10.1186/s12864-019-6344-3. BMC Genomics. 2020. PMID: 31898484 Free PMC article.

2

Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response.

Sato Y, Fu Y, Liu H, Lee MY, Shaw MH. Sato Y, et al. BMC Cancer. 2021 Nov 13;21(1):1222. doi: 10.1186/s12885-021-08974-3. BMC Cancer. 2021. PMID: 34774008 Free PMC article.

3

CD4⁺ and CD8a⁺ PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer models.

Kristensen LK, Fröhlich C, Christensen C, Melander MC, Poulsen TT, Galler GR, Lantto J, Horak ID, Kragh M, Nielsen CH, Kjaer A. Kristensen LK, et al. Theranostics. 2019 Oct 18;9(26):8221-8238. doi: 10.7150/thno.37513. eCollection 2019. Theranostics. 2019. PMID: 31754392 Free PMC article.

4

Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery.

Mosely SI, Prime JE, Sainson RC, Koopmann JO, Wang DY, Greenawalt DM, Ahdesmaki MJ, Leyland R, Mullins S, Pacelli L, Marcus D, Anderton J, Watkins A, Coates Ulrichsen J, Brohawn P, Higgs BW, McCourt M, Jones H, Harper JA, Morrow M, Valge-Archer V, Stewart R, Dovedi SJ, Wilkinson RW. Mosely SI, et al. Cancer Immunol Res. 2017 Jan;5(1):29-41. doi: 10.1158/2326-6066.CIR-16-0114. Epub 2016 Dec 6. Cancer Immunol Res. 2017. PMID: 27923825 Free article.

5

Concomitant blockade of A2AR and CTLA-4 by siRNA-loaded polyethylene glycol-chitosan-alginate nanoparticles synergistically enhances antitumor T-cell responses.

Ghasemi-Chaleshtari M, Kiaie SH, Irandoust M, Karami H, Nabi Afjadi M, Ghani S, Aghaei Vanda N, Ghaderi Sede MJ, Ahmadi A, Masjedi A, Hassannia H, Atyabi F, Hojjat-Farsangi M, Namdar A, Ghalamfarsa G, Jadidi-Niaragh F. Ghasemi-Chaleshtari M, et al. J Cell Physiol. 2020 Dec;235(12):10068-10080. doi: 10.1002/jcp.29822. Epub 2020 Jun 2. J Cell Physiol. 2020. PMID: 32488862

6

Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19-IL2 cures poorly immunogenic tumors when combined with radiotherapy.

Olivo Pimentel V, Marcus D, van der Wiel AM, Lieuwes NG, Biemans R, Lieverse RI, Neri D, Theys J, Yaromina A, Dubois LJ, Lambin P. Olivo Pimentel V, et al. J Immunother Cancer. 2021 Mar;9(3):e001764. doi: 10.1136/jitc-2020-001764. J Immunother Cancer. 2021. PMID: 33688020 Free PMC article.

7

Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumors.

Davis-Marcisak EF, Fitzgerald AA, Kessler MD, Danilova L, Jaffee EM, Zaidi N, Weiner LM, Fertig EJ. Davis-Marcisak EF, et al. Genome Med. 2021 Aug 11;13(1):129. doi: 10.1186/s13073-021-00944-5. Genome Med. 2021. PMID: 34376232 Free PMC article.

8

Infiltration of Immune Competent Cells into Primary Tumors and Their Surrounding Connective Tissues in Xenograft and Syngeneic Mouse Models.

Metzen M, Bruns M, Deppert W, Schumacher U. Metzen M, et al. Int J Mol Sci. 2021 Apr 19;22(8):4213. doi: 10.3390/ijms22084213. Int J Mol Sci. 2021. PMID: 33921688 Free PMC article.

9

Anti-KIT Monoclonal Antibody Treatment Enhances the Antitumor Activity of Immune Checkpoint Inhibitors by Reversing Tumor-Induced Immunosuppression.

Garton AJ, Seibel S, Lopresti-Morrow L, Crew L, Janson N, Mandiyan S, Trombetta ES, Pankratz S, LaVallee TM, Gedrich R. Garton AJ, et al. Mol Cancer Ther. 2017 Apr;16(4):671-680. doi: 10.1158/1535-7163.MCT-16-0676. Epub 2017 Jan 30. Mol Cancer Ther. 2017. PMID: 28138031

10

Modeling Immune Checkpoint Inhibitor Efficacy in Syngeneic Mouse Tumors in an Ex Vivo Immuno-Oncology Dynamic Environment.

Doty DT, Schueler J, Mott VL, Bryan CM, Moore NF, Ho JC, Borenstein JT. Doty DT, et al. Int J Mol Sci. 2020 Sep 4;21(18):6478. doi: 10.3390/ijms21186478. Int J Mol Sci. 2020. PMID: 32899865 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year